These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 16034712)
1. Effect of alendronate administration on bone mineral density and bone strength in castrated rats. Broulik PD; Rosenkrancová J; Růzicka P; Sedlácek R Horm Metab Res; 2005 Jul; 37(7):414-8. PubMed ID: 16034712 [TBL] [Abstract][Full Text] [Related]
2. The effect of chronic nicotine administration on bone mineral content and bone strength in normal and castrated male rats. Broulik PD; Rosenkrancová J; Růzicka P; Sedlácek R; Kurcová I Horm Metab Res; 2007 Jan; 39(1):20-4. PubMed ID: 17226109 [TBL] [Abstract][Full Text] [Related]
3. The effect of chronic alcohol administration on bone mineral content and bone strength in male rats. Broulík PD; Vondrová J; Růzicka P; Sedlácek R; Zíma T Physiol Res; 2010; 59(4):599-604. PubMed ID: 19929136 [TBL] [Abstract][Full Text] [Related]
4. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts. Shu G; Yamamoto K; Nagashima M Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994 [TBL] [Abstract][Full Text] [Related]
5. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat. Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458 [TBL] [Abstract][Full Text] [Related]
6. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats. Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005 [TBL] [Abstract][Full Text] [Related]
7. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge. Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966 [TBL] [Abstract][Full Text] [Related]
8. Effect of oviductus ranae and oviductus ranae eggs on bone metabolism and osteoporosis. Wang DH; Wu W; Tian JM; Wang ZH; Wang DT; Xiang K; Zhu GY; Han T Chin J Integr Med; 2013 Jul; 19(7):532-8. PubMed ID: 23263999 [TBL] [Abstract][Full Text] [Related]
9. Alendronate influences bending force of femoral diaphysis after orchidectomy in rats. Huuskonen J; Arnala I; Olkkonen H; Alhava E Ann Chir Gynaecol; 2001; 90(2):109-14. PubMed ID: 11459259 [TBL] [Abstract][Full Text] [Related]
11. Alendronate disturbs vesicular trafficking in osteoclasts. Alakangas A; Selander K; Mulari M; Halleen J; Lehenkari P; Mönkkönen J; Salo J; Väänänen K Calcif Tissue Int; 2002 Jan; 70(1):40-7. PubMed ID: 11907706 [TBL] [Abstract][Full Text] [Related]
12. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment. Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202 [TBL] [Abstract][Full Text] [Related]
14. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet. Kobayashi M; Hara K; Akiyama Y Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039 [TBL] [Abstract][Full Text] [Related]
15. Alendronate therapy in cyclosporine-induced alveolar bone loss in rats. Spolidorio LC; Marcantonio E; Spolidorio DM; Nassar CA; Nassar PO; Marcantonio RA; Rossa C J Periodontal Res; 2007 Oct; 42(5):466-73. PubMed ID: 17760825 [TBL] [Abstract][Full Text] [Related]
16. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. Aspenberg P; Agholme F; Magnusson P; Fahlgren A Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557 [TBL] [Abstract][Full Text] [Related]
17. Prolonged overdose of all-trans retinoic acid enhances bone sensitivity in castrated mice. Broulík PD; Raška I; Brouliková K Nutrition; 2013 Sep; 29(9):1166-9. PubMed ID: 23830742 [TBL] [Abstract][Full Text] [Related]
18. Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys. Yamagami Y; Mashiba T; Iwata K; Tanaka M; Nozaki K; Yamamoto T Bone; 2013 May; 54(1):1-7. PubMed ID: 23356990 [TBL] [Abstract][Full Text] [Related]
19. Exercise prevented the lansoprazole-induced reduction of anti-osteoporotic efficacy of alendronate in androgen deficiency rats. Cegieła U; Pytlik M; Folwarczna J; Miozga R; Piskorz S; Nowak D Acta Pol Pharm; 2014; 71(3):485-95. PubMed ID: 25265829 [TBL] [Abstract][Full Text] [Related]
20. The influence of nitric oxide synthase inhibitor L-NAME on bones of male rats with streptozotocin-induced diabetes. Broulík PD; Haluzík M; Skrha J Physiol Res; 2003; 52(6):729-34. PubMed ID: 14640894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]